Condition: Multiple Sclerosis · Multiple Sclerosis, Secondary Progressive · Multiple Sclerosis Relapse · Sponsor: Shirley Ryan AbilityLab
The purpose of this study is to develop a measurement of walking quality, called Gait Deviation Index (GDI) for people with Multiple Sclerosis (MS).
This description comes directly from the study's public registry record.
Weena Dee · 312-328-7503 · wdee@sralab.org
Alex Barry · 312-238-1435 · abarry@sralab.org
Always discuss trial participation with your own doctor first.
| Shirley Ryan AbilityLab | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06516458